Acute Respiratory Failure Clinical Trial
Official title:
Concurrent Trigger Sensitivity Adjustment And Diaphragmatic Facilitation On Weaning Of Patients From Mechanical Ventilation
Verified date | August 2023 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
As Acute respiratory failure (ARF) is a challenging serious condition especially when it necessitates intubation to deliver mechanical ventilation which is a fundamental strategy for supporting the respiratory function when the patient can't bear all work of breathing. Even if it represents a life-saving procedure, mechanical ventilation (MV) is associated to life-threatening complications as respiratory muscle dysfunction, and atrophy that lead to long stay in intensive care unit (ICU) and higher mortality. Weaning difficulty is experienced in nearly 30 percent of critically ill patients. The decision to extubate mechanically ventilated patients should be aimed at preventing both the risk of premature liberation from MV which is associated with poor outcome and the risk of delayed extubation which increases the complications of prolonged MV and there is increasing evidence that MV itself may adversely affect the diaphragm's structure and function, which has been termed ventilator-induced diaphragmatic dysfunction (VIDD). The combination of positive pressure ventilation and positive end-expiratory pressure may unload the diaphragm which leads to changes in myofibril length and rapid atrophy that occurs within hours of MV, caused by an imbalance between protein synthesis and proteolysis, lead to a large reduction in the inspiratory pressure generated by the diaphragm.
Status | Completed |
Enrollment | 75 |
Est. completion date | November 30, 2022 |
Est. primary completion date | October 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patients of both sexes with age ranges (50-60) years old. - Patients will be referred with acute respiratory failure (ARF) inside ICU. - All patients are intubated and mechanically ventilated with assisted control (pressure or volume) or pressure support modes for 24-48 hours. - All patients with positive end expiratory pressure (PEEP) don't exceed 10 cmH2o. - All patients are hemodynamically stable; temperature (36.2-37.5) C, Heart rate < 140 /min, Blood pressure (systolic: <180mmHg and diastolic <100 mmHg), Respiratory rate < 35/min and oxygen saturation >90% - All patients are conscious and responsive to verbal command. Exclusion Criteria: - Fraction of inspired oxygen (fio2)>0.6 and SPO2 < 85% to avoid further hypoxia and respiratory distress. - Positive end expiratory pressure (PEEP) > 10 cmH2O to avoid barotrauma. - Severe pulmonary condition; acute pulmonary embolism, undrained pneumothorax. - Unstable hemodynamic condition as defined by heart rate more than 140 beats/min, systolic blood pressure >180 mmHg or Low blood pressure < 80 mmHg and respiratory rate is exceeding 35 breaths/min. - Patients who develop any cardiac condition during the course of treatment; acute myocardial infarction or cardiac arrhythmia. - Patients who recently have undergo cardiac or abdominal or gynecological surgery. - Active lung infection like tuberculosis. - Chest trauma such as rib fracture, flail chest, thoracic vertebra fracture or chest burns. - Spinal cord injuries involved the phrenic nerve. - Active bleeding as alveolar hemorrhage, hemoptysis. - Heavy sedation that depresses respiratory drive or ability to follow commands. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of physical therapy - Cairo University | Giza |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood gases analysis | Blood gases analyzer(SIEMENS RAPIDLAB 1265, manufactured in 2008) is used in every clinical diagnosis lab or critical care facility to measure blood gases (PH, pco2 and po2), electrolytes, and metabolites parameters from whole blood samples. An arterial blood catheter (cannula) was inserted into the radial artery to draw blood sample of (2 to 3) ml, in a (3 to 5) ml plastic airtight syringe fitted with a small bore needled and filled with heparin.
The standard values: PH 7.35-7.45, PaCO2 35-45, PaO2 60-100, SPO2 95-100% and PaO2/FiO2 ratio >300. |
Blood gases will be analyzed and recorded for all patients pre and post the treatment program duration 5 up to 7 days | |
Primary | Oxygenation Index (OI) | OI is recognized as the primary indicator for respiratory disease severity stratification in mechanically ventilated patients to assess the intensity of ventilatory support that needed to maintain adequate oxygenation and predict outcomes in patients with ARF.
OI = (FiO2 x MAP) / PaO2 OI normally, <15 as the lower the OI the better the outcome: as the oxygenation of the patient improves, they can achieve a higher PaO2 at a lower FiO2. |
OI will be recorded for three study groups pre and post the treatment program duration 5 up to 7 days | |
Primary | Maximum Inspiratory Pressure (MIP) | MIP also known as negative inspiratory force (NIF); the maximum negative pressure generated for at least 1 second during maximal inspiratory effort against occluded airway that estimated inspiratory muscle strength mainly diaphragm. PImax has been widely used to quantify respiratory muscle weakness. PImax values of more than -25 cmH2O was considered as an index to predict weaning success.
To obtain reliable results, the maneuver will be performed three times, with a 1-min interval between readings. The highest value was chosen as PImax. |
MIP will be measured digitally from the MV for all patients pre and post the treatment program duration 5 up to 7 days. | |
Primary | Rapid shallow breathing index (RSBI) | RSBI is an index used to predict weaning from MV, defined as the ratio of respiratory frequency to tidal volume (f/VT). People on MV who cannot tolerate independent breathing tend to breath rapidly (high frequency) and shallowly (low tidal volume) and will therefore have a high RSBI. RSBI<105 is reported to be the most accurate predictor of successful patient extubation.
ventilator mode was switched on CPAP with zero pressure support to divide f by Vt to obtain RSBI (f/Vt). |
RSBI was measured for all patients pre and post the treatment program duration 5 up to 7 days | |
Primary | Weaning Success Rate | Weaning success is defined as spontaneous breathing without mechanical support for at least 48 hours. Weaning success rate (a proportion of successfully weaned patients to total number of patients receiving a treatment program) | it will be recorded for three study groups post the treatment program duration 5 up to 7 days |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05144633 -
Blue Protocol and Eko Artificial Intelligence Are Best (BEA-BEST)
|
||
Completed |
NCT04534569 -
Expert Panel Statement for the Respiratory Management of COVID-19 Related Acute Respiratory Failure (C-ARF)
|
||
Recruiting |
NCT03021902 -
Nutrition and Exercise in Critical Illness
|
Phase 2 | |
Completed |
NCT02902146 -
Bougie Use in Emergency Airway Management
|
N/A | |
Completed |
NCT02901158 -
Esophageal Manometry in Mechanically Ventilated Patients
|
||
Completed |
NCT02236559 -
High Flow Therapy for the Treatment of Respiratory Failure in the ED
|
N/A | |
Recruiting |
NCT02056093 -
Comparison of Proportional Assist Ventilation And Neurally Adjusted Ventilator Assist
|
N/A | |
Not yet recruiting |
NCT01668368 -
Goal Directed Mechanical Ventilation Aimed at Optimal Lung Compliance
|
N/A | |
Terminated |
NCT01083277 -
Variable Ventilation During Acute Respiratory Failure
|
N/A | |
Completed |
NCT01462279 -
Effect of Thiamine on Oxygen Utilization (VO2) in Critical Illness
|
N/A | |
Completed |
NCT01114022 -
Prevention Inhalation of Bacterial by Using Endotracheal Tube Balloon Polyvinyl Chloride or Polyurethane
|
N/A | |
Active, not recruiting |
NCT01058421 -
Treatment of Critical Illness Polyneuromyopathy
|
Phase 2 | |
Completed |
NCT00252616 -
Timing of Target Enteral Feeding in the Mechanically Ventilated Patient
|
Phase 2/Phase 3 | |
Recruiting |
NCT04098094 -
Outcomes of RV Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases
|
||
Recruiting |
NCT06051292 -
Decremental Esophageal Catheter Filling Volume Titration For Transpulmonary Pressure Measurement
|
N/A | |
Completed |
NCT04601090 -
Survival Rates and Longterm Outcomes After COVID-19
|
||
Recruiting |
NCT05423301 -
Global Physiotherapy in ICU Patients With High Risk Extubation Failure
|
N/A | |
Completed |
NCT02447692 -
Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study
|
N/A | |
Completed |
NCT04016480 -
HFNC During Bronchoscopy for Bronchoalveolar Lavage
|
N/A | |
Completed |
NCT04507425 -
High Flow Nasal Cannula With Noninvasive Ventilation
|
N/A |